TCL Archive Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development. January 13, 2006
TCL Archive Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities July 28, 2000
TCL Archive DCCR Cancer Information Systems Program Renewed For Three More Years; Two Dropped, Two Added September 1, 1978